Current management of polycythemia vera

Leukemia and Lymphoma

Volumn 43, Issue 1, 2002, Pages 1-7

  Tefferi, Ayalew ^a  

^a MAYO CLINIC   (United States)

Author keywords

Anagrelide; Aspirin; Busulfan; Hydroxyurea; Interferon alfa; Pipobroman; Polycythemia

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA INTERFERON; ANAGRELIDE; BUSULFAN; CHLORAMBUCIL; CYCLOOXYGENASE 1 INHIBITOR; DIPYRIDAMOLE; HYDROXYUREA; PHOSPHORUS 32; PIPOBROMAN; ANTINEOPLASTIC AGENT;

ACUTE LEUKEMIA; ARTICLE; BONE MARROW BIOPSY; CONTROLLED STUDY; CYTOPENIA; DIGESTIVE SYSTEM CANCER; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFECT; DRUG EFFICACY; DRUG EXCRETION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; DRUG SPECIFICITY; DRUG TOLERABILITY; FLU LIKE SYNDROME; GASTROINTESTINAL HEMORRHAGE; HEADACHE; HUMAN; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; MYELOFIBROSIS; MYELOID METAPLASIA; NEUTROPENIA; PHLEBOTOMY; POLYCYTHEMIA VERA; PRIORITY JOURNAL; SKIN CANCER; ACUTE DISEASE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; DISEASE MANAGEMENT; MYELOID LEUKEMIA; PATHOLOGY; REVIEW;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MANAGEMENT; HUMANS; LEUKEMIA, MYELOID; POLYCYTHEMIA VERA;

EID: 0036119499     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190210200     Document Type: Article

References (72)

1. "Some speculations on the myeloproliferative syndromes"
2. "Polycythemia vera: Stem-cell and probable clonal origin of the disease"
3. "Trends in the incidence of polycythemia vera among Olmsted County Minnesota residents, 1935-1989"
4. "Polycythemia vera: The natural history of 1213 patients followed for 20 years"
5. "Life expectancy of patients with chronic nonleukemic myeloproliferative disorders"
6. "Treatment of polycythemia vera: A summary of clinical trials conducted by the Polycythemia Vera Study Group"
7. "Diagnosis and classification of the polycythemias"
8. "Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin"
9. "Determination of serum immunoreactive erythropoietin in the investigation of erythrocytosis"
10. "The diagnostic criteria of polycythaemia rubra vera"
11. "Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group"
12. "Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera"
13. "Immunohistochemical staining for megakaryocyte c-mpl may complement morphologic distinction between polycythemia vera and secondary erythrocytosis"
14. "Diagnosing polycythemia vera: A paradigm shift"
15. "Normal ranges for packed cell volume and hemoglobin concentration in adults: Relevance to apparent polycythemia"
16. "Plasma erythropoietin by high-detectability immunoradiometric assay in untreated and treated patients with polycythaemia vera and essential thrombocythaemia"
17. "Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment"
18. "Low serum erythropoietin-a strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels"
19. "Radioimmunoassay of immunoreactive erythropoietin as a clinical tool for the classification of polycythaemias"
20. "Serum erythropoietin in the diagnosis of polycythemia vera. A follow-up study"
21. "Prediction of clinical course in patients with idiopathic erythrocytosis by endogenous erythroid colony assay but not by serum erythropoietin levels"
22. "Identification of masked polycythemia vera from patients with idiopathic marked thrombocytosis by endogenous erythroid colony assay"
23. "Diagnostic applications of haemopoietic progenitor culture techniques in polycythaemias and thrombocythaemias"
24. "Transient neurologic and ocular manifestations in primary thrombocythemia"
25. "A review of pruritus"
26. "Polycythemia rubra vera"
27. "Long-term management of polycythemia vera with hydroxyurea: A progress report"
28. "Sur une forme spéciale de cyanose s'accompagnant d'hyperglobulie excessive et pérsistante"
29. "Course of polycythemia"
30. "The nature and treatment of polycythemia: Studies on 263 patients"
31. "Complications and causes of death in polycythaemia vera"
32. "From efficacy to safety: A Polycythemia Vera Study Group report on hydroxyurea in patients with Polycythemia vera"
33. "Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols"
34. "Cerebral blood-flow in polycythaemia"
35. "Transport of oxygen to the brain in patients with elevated haematocrit values before and after venesection"
36. "Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia"
37. "The course and complications of idiopathic erythrocytosis"
38. 32P between 1969 and 1981"
39. "Increased incidence of acute leukemia in polycythemia vera associated with chlorambucil therapy"
40. "Treatment of polycythemia vera: The use of hydroxyurea and pipobroman in 292 patients under the age of 65 years"
41. 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age
42. "Treatment on polycythaemia vera by radiophosphorus or busulphan: A randomized trial"
43. "Treatment of polycythemia vera with hydroxyurea"
44. "Management of polycythemia vera with hydroxyurea"
45. "Hydroxyurea in the treatment of polycythemia vera: A prospective study of 100 patients over a 20-year period"
46. "Experience of the Polycythemia Vera Study Group with essential thrombocythemia: A final report on diagnostic criteria, survival, and leukemic transition by treatment"
47. "Interferon alfa: Effects of long-term treatment for polycythemia vera"
48. "Interferon-alpha therapy in polycythemia vera and essential thrombocythemia"
49. "Clinical toxicity of interferons in cancer patients: A review"
50. "A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera"
51. "Efficacy of recombinant interferon-alpha (rIFN-alpha) in polycythaemia vera: A study of 17 patients and an analysis of published data"
52. "Inhibition of platelet function by antithrombotic agents which selectively inhibit low-Km cyclic 3′,5′-adenosine monophosphate phosphodiesterase"
53. "Inhibition of platelet production induced by an antiplatelet drug, anagrelide, in normal volunteers"
54. "Disposition of anagrelide, an inhibitor of platelet aggregation"
55. "Anagrelide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in the treatment of thrombocythaemia"
56. "Anagrelide: A potent and selective inhibitor of platelet cyclic AMP phosphodiesterase enzyme activity"
57. "Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders"
58. "The effects of anagrelide on human megakaryocytopoiesis"
59. "Analysis of the mechanism of anagrelide-induced thrombocytopenia in humans"
60. "Anagrelide: A new drug for treating thrombocytosis"
61. "Anagrelide, a therapy for thrombocythemic states: Experience in 577 patients"
62. "Therapy with anagrelide in patients affected by essential thrombocythemia: Preliminary results"
63. "Anagrelide for control of thrombocythemia in polycythemia and other myeloproliferative disorders"
64. "Adverse effects of antiaggregating platelet therapy in the treatment of polycythemia vera"
65. "Increased thromboxane biosynthesis in patients with polycythemia vera: Evidence for aspirin-suppressible platelet activation in vivo"
66. "Increased thromboxane biosynthesis in essential thrombocythemia"
67. "Low-dose aspirin in polycythaemia vera: A pilot study"
68. "European Collaboration on Low-dose Aspirin in Polycythemia vera (ECLAP): A randomized trial"
69. "Acquired von Willebrand's disease in the myeloproliferative syndrome"
70. "Chronic myeloproliferative diseases: Polycythemia vera and agnogenic myeloid metaplasia"
71. "A clinical update in polycythemia vera and essential thrombocythemia"
72. "Recent progress in the pathogenesis and management of essential thrombocythemia"